Results 81 to 90 of about 19,032,231 (358)

Mitigating climate change must be a priority for public health

open access: yesThe Lancet Public Health, 2021
The Lancet Public Health
doaj   +1 more source

Public funding, public knowledge, publication

open access: yesSerials: The Journal for the Serials Community, 2003
The argument that publicly funded research should be publicly available is a valid one, but it cannot be the most important one in the discussion as to whether research should be freely accessible. The overriding argument is that freely accessible research optimises the scientific process as well as its 'translation' into societal benefits. Free access,
openaire   +2 more sources

Hugh Freund ’11 Captures Silver Medal in 2016 Paralympics [PDF]

open access: yes, 2016
Part of a three-man sailing team, architecture alumnus wins silver in Rio ...
Public Affairs, Roger Williams University
core   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

open access: yesMolecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz   +12 more
wiley   +1 more source

University Awarded ‘Military Friendly’ Honors by G.I. Jobs [PDF]

open access: yes, 2011
The honor follows a range of ‘military friendly’ accolades earned by Roger Williams in recent ...
Public Affairs, Roger Williams University
core   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy